Biote Corp./$BTMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
Ticker
$BTMD
Sector
Primary listing
Employees
223
Headquarters
Website
Biote Corp. Metrics
BasicAdvanced
$70m
2.96
$0.74
1.14
-
Price and volume
Market cap
$70m
Beta
1.14
52-week high
$4.75
52-week low
$1.27
Average daily volume
278k
Financial strength
Current ratio
1.215
Quick ratio
0.707
Long term debt to equity
-204.536
Total debt to equity
-218.112
Dividend payout ratio (TTM)
6.39%
Interest coverage (TTM)
3.20%
Profitability
EBITDA (TTM)
39.221
Gross margin (TTM)
71.46%
Net profit margin (TTM)
14.07%
Operating margin (TTM)
18.24%
Effective tax rate (TTM)
15.93%
Revenue per employee (TTM)
$860,000
Management effectiveness
Return on assets (TTM)
19.06%
Return on equity (TTM)
-41.41%
Valuation
Price to earnings (TTM)
2.959
Price to revenue (TTM)
0.356
Price to book
-1.15
Price to tangible book (TTM)
-0.92
Price to free cash flow (TTM)
2.418
Free cash flow yield (TTM)
41.35%
Free cash flow per share (TTM)
0.906
Growth
Revenue change (TTM)
-2.52%
Earnings per share change (TTM)
722.22%
3-year revenue growth (CAGR)
5.23%
3-year earnings per share growth (CAGR)
83.26%
Biote Corp. News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Biote Corp. stock?
Biote Corp. (BTMD) has a market cap of $70M as of May 04, 2026.
What is the P/E ratio for Biote Corp. stock?
The price to earnings (P/E) ratio for Biote Corp. (BTMD) stock is 2.96 as of May 04, 2026.
Does Biote Corp. stock pay dividends?
No, Biote Corp. (BTMD) stock does not pay dividends to its shareholders as of May 04, 2026.
When is the next Biote Corp. dividend payment date?
Biote Corp. (BTMD) stock does not pay dividends to its shareholders.
What is the beta indicator for Biote Corp.?
Biote Corp. (BTMD) has a beta rating of 1.14. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.